HR Execs on the Move

Frontage Laboratories

www.frontagelab.com

 
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details
Larry Veal
SVP, Sales and Marketing Profile

Similar Companies

Chandler Group

Chandler Group is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Custom Spine Inc

Custom Spine Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Parsippany, NJ. To find more information about Custom Spine Inc, please visit www.customspine.com

Fluortek

Fluortek is a Easton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Express Medical Transporters

Express Medical Transporters is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.